Since the Centers for Medicare and Medicaid Services launched the Acute Hospital Care at Home (AHCaH) Waiver in 2020, thousands of patients from across 300 hospitals in 37 states have been treated in their homes.
Rocket’s gene therapy gets a PDUFA date; SAB Biotherapeutics’ $130M; Acurix to move to PhIII
Plus, more news from Amicus Therapeutics, Mogrify, and Clade Therapeutics. Rocket gets a March date with FDA: The FDA has until March 31 to decide
October 3, 2023